Skip to main content
SpringerLink
Log in

The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Serial mild whole-body hyperthermia is a widely used balneotherapy modality for clinically inactive ankylosing spondylitis (AS) in rehabilitative medicine. Thus far, the mechanisms of its favorable influence on the symptoms of AS are not completely understood. We therefore analyzed the effect of mild whole-body hyperthermia on the systemic levels of pivotal proinflammatory cytokines. Twelve male subjects with AS and 12 healthy control subjects received nine cycles of whole-body hyperthermia (target body core temperature, 38.5°C; duration, 50 min). Serum samples were taken at the beginning of the last cycle and at 1, 6, and 24 h for measurement of tumor necrosis factor α, interleukin 1β and interleukin 6. Significant differences of cytokine levels were found between both groups. In AS patients, hyperthermia caused a significant reduction of all cytokines by 40–50%. Thus, serial mild whole-body hyperthermia in AS results in heat-induced changes of the proinflammatory cytokine network.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Panush RS (2000) American College of Rheumatology position statement: complementary and alternative therapies for rheumatic disease. Rheum Dis Clin North Am 26:189–192

    Article  Google Scholar 

  2. Hentschel HD, Nold F, Regehr I (1969) Beobachtungen bei der Überwärmungstherapie der ankylosierenden Spondylitis. Verh Dtsch Ges Rheumatol 1:184–188

    PubMed  CAS  Google Scholar 

  3. Bühring M, Bork-Wölwer L, Krippner H, Pirlet K (1977) Quantitative Veränderungen peripherer T-Lymphozyten unter Hyperthermie. MMW Münch Med Wochenschr 119:1591–1594

    PubMed  Google Scholar 

  4. Bühring M, Bork-Wölwer L, Krippner H (1978) Peripheral T lymphocytopenia under exogenous thermal stress. Cancer 42:2794–2797

    Article  PubMed  Google Scholar 

  5. Schmidt KL (1987) Hyperthermie und Fieber. Wirkungen bei Mensch und Tier. Klinik, Pathologie, Immunologie, Wirkungen auf Entzündungen. Hippokrates Verlag, Stuttgart

  6. Schmidt KL, Simon E (2001) Thermotherapy of pain, trauma and inflammatory and degenerative rheumatic diseases. In: Kosaka M, Sugahara T, Schmidt KL, Simon E (eds) Thermotherapy for neoplasia, inflammation, and pain. Springer, Tokyo, pp 527–539

    Google Scholar 

  7. Schmidt KL (2004) Zur Wirkung der Ganzkörperhyperthermie auf Entzündungen und Immunreaktionen: experimentelle Grundlagen. Phys Rehab Kur Med 14:1–9

    Article  Google Scholar 

  8. Schleenbecker H, Schmidt KL (1998) Zur Wirkung einer iterativen milden Ganzkörper-Hyperthermie auf den Fibromyalgieschmerz. Phys Rehab Kur Med 8:113–117

    Article  Google Scholar 

  9. Hori T, Kaizuka Y, Takaki A, Katafuchi T (2001) Thermal stress and immunity. In: Kosaka M, Sugahara T, Schmidt KL, Simon E (eds) Thermotherapy for neoplasia, inflammation, and pain. Springer, Tokyo, pp 242–251

    Google Scholar 

  10. Lange U, Thielen G, Neeck G, Schmidt KL (2005) Einfluss der milden Hyperthermie auf die Blutspiegel von Kortisol und Lymphozytensubpopulationen bei Patienten mit ankylosierender Spondylitis und Gesunden. Phys Med Rehab Kuror 15:44–47

    Article  Google Scholar 

  11. Braun J (2002) Stadiensystem radiographischer Einteilung. In: Braun J, Sieper J (eds) Spondylitis ankylosans. Uni-Med, Bremen, p 114

    Google Scholar 

  12. Sobieska M, Stratz T, Samborski W et al (1993) Interleukin-6 (IL-6) after whole body cryotherapy and local hot mud pack treatment [letter]. Eur J Phys Med Rehabil 3:205

    Google Scholar 

  13. Olszewski WL, Grzelak I, Ziolkowska A, Engeset A (1989) Effect of local hyperthermia on lymph immune cells and lymphokines of normal human skin. J Surg Oncol 41:109–116

    Article  PubMed  CAS  Google Scholar 

  14. Bellometti S, Galzigna L (1998) Serum levels of a prostaglandin and a leukotriene after thermal mud pack therapy. J Investig Med 46:140–145

    PubMed  CAS  Google Scholar 

  15. Yoshioka A, Miyachi Y, Imamura S et al (1989) Suppression of contact sensitivity by local hyperthermia treatment due to reduced Langerhans cell population in mice. Br J Dermatol 120:493–501

    Article  PubMed  CAS  Google Scholar 

  16. Huang YH, Haegerstrand A, Frostegård J (1996) Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol 103:61–66

    Article  PubMed  CAS  Google Scholar 

  17. Shen RN, Hornback NB, Shidnia H et al (1991) Whole body hyperthermia: a potent radioprotector in vivo. Int J Radiat Oncol Biol Phys 20:525–530

    PubMed  CAS  Google Scholar 

  18. Tütüncü ZN, Turan M, Yüzbasioglu N, Karagülle MZ (1996) Changes in TNFα plasma levels in osteoarthritis patients under balneotherapy with acratothermal water. Phys Rehab Kur Med 6:80–82

    Article  Google Scholar 

  19. Tütüncü ZN, Bilgie A, Kennedy LG, Calin A (1994) Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 53:425–426

    Article  PubMed  Google Scholar 

  20. Gratacós J, Collado A, Filella X et al (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33:927–931

    Article  PubMed  Google Scholar 

  21. Falkenbach A, Herold M (1998) In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility. Rheumatol Int 18:103–106

    Article  PubMed  CAS  Google Scholar 

  22. Gratacós J, Collado A, Pons F et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 42:2319–2324

    Article  PubMed  Google Scholar 

  23. Bal A, Unlu E, Bahar G et al (2007) Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 26:211–215

    Article  PubMed  CAS  Google Scholar 

  24. Park MC, Lee SW, Choi ST et al (2007) Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 36:101–106

    Article  PubMed  CAS  Google Scholar 

  25. Brandt J, Haibel H, Cornely D et al (2000) Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43:1346–1352

    Article  PubMed  CAS  Google Scholar 

  26. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507–511

    PubMed  CAS  Google Scholar 

  27. Chou CT, Huo AP, Chang HN et al (2007) Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives. Arch Med Res 38:190–195

    Article  PubMed  CAS  Google Scholar 

  28. François RJ, Neure L, Sieper J, Braun J (2006) Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 65:713–720

    Article  PubMed  Google Scholar 

  29. Vazquez-Del MM, Garcia-Gonzalez A, Muñoz-Valle JF et al (2002) Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis. J Rheumatol 29:522–526

    PubMed  Google Scholar 

  30. Rudwaleit M, Siegert S, Yin Z et al (2001) Low T cell production of TNFα and IFNγ in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60:36–42

    Article  PubMed  CAS  Google Scholar 

  31. Furst D, Breedveld FC, Kalden JR et al (2007) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis 66(Suppl III):iii2–iii22

    Article  PubMed  CAS  Google Scholar 

  32. Maini RN, Taylor PC, Szechinski J, CHARISMA Study Group et al (2006) Double-blind, randomized controlled trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 54:2817–2829

    Article  PubMed  CAS  Google Scholar 

  33. Wendling D, Racadot E, Toussirot E, Wijdenes J (1996) Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy. Br J Rheumatol 35:1330

    Article  PubMed  CAS  Google Scholar 

  34. Toussirot E, Lafforgue P, Boucraut J et al (1994) Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies. Rheumatol Int 13:175–180

    Article  PubMed  CAS  Google Scholar 

  35. Tan AL, Marzo-Ortega H, O’Connor P et al (2004) Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann Rheum Dis 63:1041–1045

    Article  PubMed  CAS  Google Scholar 

  36. Haibel H, Rudwaleit M, Listing J, Sieper J (2005) Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Ann Rheum Dis 64:296–298

    Article  PubMed  CAS  Google Scholar 

  37. Bennett AN, Tan AL, Coates LC et al (2008) Sustained response to anakinra in ankylosing spondylitis. Rheumatology 47:223–224

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Rheumatology, Division of Rheumatology, Clinical Immunology and Physical Medicine, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Benekestrasse 2-8, 61231, Bad Nauheim, Germany

    Ingo H. Tarner, Ulf Müller-Ladner & Uwe Lange

  2. Department of Internal Medicine II, Center for Naturopathy Treatment, University of Jena, Jena, Germany

    Christine Uhlemann

Authors
  1. Ingo H. Tarner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulf Müller-Ladner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine Uhlemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Uwe Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ingo H. Tarner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarner, I.H., Müller-Ladner, U., Uhlemann, C. et al. The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis. Clin Rheumatol 28, 397–402 (2009). https://doi.org/10.1007/s10067-008-1059-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1059-x

Keywords

Search

Navigation